Market Overview

The global breast cancer liquid biopsy market size was valued at USD 103.03 million in 2022. It is projected to reach USD 474.62 million by 2031, growing at a CAGR of 18.50% during the forecast period (2023-2031). 

The global Breast Cancer Liquid Biopsy market is witnessing swift transformation driven by new consumer behaviors, increased funding, and advancements in technology. According to Straits Research, the industry is further propelled by rising digital adoption, supportive government policies, expanding industrial applications, and a growing focus on operational efficiency and sustainability across markets. This section outlines the current market landscape, focusing on key trends, rising opportunities, major competitive actions, and the elements influencing the industry’s growth path.

Download Free Sample Report PDF (Includes Full TOC, Charts, Tables & Figures): https://straitsresearch.com/report/breast-cancer-liquid-biopsy-market/request-sample

Market Scope and Research Approach

This study integrates both quantitative metrics and qualitative evaluations to provide a clear, accurate, and in-depth market assessment. The scope defines major parameters and market categories to give readers a structured view of the industry and its foundational dynamics.

The report analyzes market size, forecasts, and growth potential by evaluating essential segments and sub-segments. It explores critical market drivers, including regulatory policies, cost optimization, sustainability initiatives, and constant innovation. The analysis also includes competitive benchmarking, investment flow patterns, and policy frameworks influencing market evolution.

Regional Assessment

The research covers North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa. Each region is evaluated based on growth potential, market share, investment climate, and trade activity. Regional evaluations consider government initiatives, industry performance, demand shifts, and development prospects to provide a comprehensive geographic market view.

Download Free Sample Report PDF (Includes Full TOC, Charts, Tables & Figures): https://straitsresearch.com/report/breast-cancer-liquid-biopsy-market/request-sample

Market Segmentation

1. By Product and Service
   
   1. Reagent Kits
   2. Instruments
   3. Services
2. By Circulating Biomarker
   1. Circulating Tumor Cells
   2. Extracellular Vesicles
   3. Circulating Tumor DNA
3. By Applications
   1. Diagnostics
   2. Prognostics
   3. Risk assessment 

Major Market Participants

1. Biocept Inc.
2. F. Hoffmann-La Roche Ltd. (Foundation Medicine Inc.)
3. Fluxion Biosciences Inc.
4. Menarini Group (Menarini Silicon Biosystems Inc.)
5. Myriad Genetics Inc.
6. NeoGenomics Laboratories Inc.
7. Qiagen N.V.
8. Sysmex Corporation
9. Thermo Fisher Scientific Inc.
10. Guardant Health Inc.

Download Free Sample Report PDF (Includes Full TOC, Charts, Tables & Figures): https://straitsresearch.com/report/breast-cancer-liquid-biopsy-market/request-sample

Key Questions Addressed in the Breast Cancer Liquid Biopsy Market Report:

• What is the current size of the Breast Cancer Liquid Biopsy market?

• What is the projected size of the industry in the upcoming years?

• What is the estimated worldwide valuation of the Breast Cancer Liquid Biopsy market?

• What is the market growth rate?

• Which market segment holds the largest share?

• What are the primary segments within the Breast Cancer Liquid Biopsy market?

• What was the North American market valuation in 2024?

• Which region leads the global market?

• What factors are fueling market expansion?

• Who are the key industry participants?

• Which companies dominate the Breast Cancer Liquid Biopsy landscape?

About Straits Research

Straits Research delivers in-depth market intelligence and data-driven insights across multiple industries. Our reports support decision-makers, investors, and organizations in identifying growth opportunities, overcoming challenges, and shaping strategic plans for sustained success in dynamic global markets.